The 5′-end transitional CpGs between the CpG islands and retroelements are hypomethylated in association with loss of heterozygosity in gastric cancers

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Kim, Young Ho ^a   Hong, Seung Jin ^a   Jung, Yu Chae ^a   Kim, Sung Ja ^a   Seo, Eun Joo ^a   Choi, Sang Wook ^a   Rhyu, Mun Gan ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BISULFITE; CALCITRIOL RECEPTOR; CARRIER PROTEIN; CYCLIN DEPENDENT KINASE 2 INHIBITOR; DEAD BOX PROTEIN; DEAD BOX PROTEIN 53; DNA; ESTROGEN RECEPTOR BETA; GUANINE NUCLEOTIDE EXCHANGE FACTOR; MELANOMA ANTIGEN; MELANOMA ANTIGEN A2; MESOTHELIN; MUCIN; MUCIN 8; MYOSIN BINDING PROTEIN C; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN MLH1; PROTEIN PRECURSOR; RAB GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; SERINE PROTEINASE INHIBITOR; STROMAL ANTIGEN 1; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR RUNX3; TREFOIL FACTOR 2; TREFOIL PEPTIDE; UNCLASSIFIED DRUG; UVOMORULIN; MICROSATELLITE DNA;

5' UNTRANSLATED REGION; ALU SEQUENCE; ARTICLE; AUTORADIOGRAPHY; CHROMOSOME LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DENSITY; DNA METHYLATION; DNA MODIFICATION; GENE DOSAGE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LONG TERMINAL REPEAT; MICROSATELLITE MARKER; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RETROPOSON; STOMACH CANCER; TRANSCRIPTION INITIATION SITE; AGED; CHEMISTRY; COMPARATIVE STUDY; DNA FLANKING REGION; FEMALE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HETEROCHROMATIN; ISOLATION AND PURIFICATION; LONG INTERSPERSED REPEAT; MALE; MIDDLE AGED; PATHOLOGY; STOMACH MUCOSA; STOMACH TUMOR;

5' FLANKING REGION; AGED; ALU ELEMENTS; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; DOSAGE COMPENSATION, GENETIC; EPIGENESIS, GENETIC; FEMALE; GASTRIC MUCOSA; GENE DOSAGE; HETEROCHROMATIN; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMERASE CHAIN REACTION; RETROELEMENTS; STOMACH NEOPLASMS; TERMINAL REPEAT SEQUENCES;

EID: 33747662906     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-180     Document Type: Article

References (44)

1. Lasko D, Cavenee W, Nordenskjold M: Loss of constitutional heterozygosity in human cancer. Annu Rev Genet 1991, 25:281-314.
2. Kern SE, Fearon ER, Tersmette KW, Enterline JP, Leppert M, Nakamura Y, White R, Vogelstein B, Hamilton SR: Clinical and pathological associations with allelic loss in colorectal carcinoma. JAMA 1989, 261:3099-3103.
3. Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y, White R: Allelotype of colorectal carcinomas. Science 1989, 244:207-211.
4. Choi SW, Choi JR, Chung YJ, Kim KM, Rhyu MG: Prognostic implications of microsatellite genotypes in gastric carcinoma. Int J Cancer 2000, 89:378-383.
5. Choi SW, Lee KJ, Bae YA, Min KO, Kwon MS, Kim KM, Rhyu MG: Genetic classification of colorectal cancer based on chromosomal loss and microsatellite instability predicts survival. Clin Cancer Res 2002, 8:2311-2322.
6. Hong SJ, Choi SW, Lee KH, Lee S, Min KO, Rhyu MG: Preoperative genetic diagnosis of gastric carcinoma based on chromosomal loss and microsatellite instability. Int J Cancer 2005, 113:249-258.
7. Bailey JA, Carrel L, Chakravarti A, Eichler EE: Molecular evidence for a relationship between LINE-I elements and X chromosome inactivation: the Lyon repeat hypothesis. Proc Natl Acad Sci U S A 2000, 97:6634-6639.
8. Meller VH: Dosage compensation: making 1X equal 2X. Trends Cell Biol 2000, 10:54-59.
9. Lee JT: Molecular links between X-inactivation and autosomal imprinting: X-inactivation as a driving force for the evolution of imprinting? Curr Biol 2003, 13:R242-R254.
10. Yang S, Smit AF, Schwartz S, Chiaromonte F, Roskin KM, Haussler D, Miller W, Hardison RC: Patterns of insertions and their covariation with substitutions in the rat, mouse, and human genomes. Genome Res 2004, 14:517-527.
11. Hasse A, Schulz WA: Enhancement of reporter gene de novo methylation by DNA fragments from the alpha-fetoprotein control region. J Biol Chem 1994, 269:1821-1826.
12. Hata K, Sakaki Y: Identification of critical CpG sites for repression of L1 transcription by DNA methylation. Gene 1997, 189:227-234.
13. Yates PA, Burman RW, Mummaneni P, Krussel S, Turner MS: Tandem B1 elements located in a mouse methylation center provide a target for de novo DNA methylation. J Biol Chem 1999, 274:36357-36361.
14. Arnaud P, Goubely C, Pelissier T, Deragon JM: SINE retroposons can be used in vivo as nucleation centers for de novo methylation. Mol Cell Biol 2000, 20:3434-3441.
15. Hansen RS: X inactivation-specific methylation of LINE-1 elements by DNMT3B: implications for the Lyon repeat hypothesis. Hum Mol Genet 2003, 12:2559-2567.
16. Kang MI, Rhyu MG, Kim YH, Jung YC, Hong SJ, Cho CS, Kim HS: The length of CpG islands is associated with the distribution of Alu and L1 retroelements. Genomics 2006, 87:580-590.
17. Grewal SI, Moazed D: Heterochromatin and epigenetic control of gene expression. Science 2003, 301:798-802.
18. Meunier J, Khelifi A, Navratil V, Duret L: Homology-dependent methylation in primate repetitive DNA. Proc Natl Acad Sci U S A 2005, 102:5471-5476.
19. Matsuzaki K, Deng G, Tanaka H, Kakar S, Miura S, Kim YS: The relationship between global methylation level, loss of heterozygosity, and microsatellite instability in sporadic colorectal cancer. Clin Cancer Res 2005, 11:8564-8569.
20. Hong SJ, Kim YH, Choi YD, Min KO, Choi SW, Rhyu MG: Relationship between the extent of chromosomal losses and the pattern of CpG methylation in gastric carcinomas. J Korean Med Sci 2005, 20:790-805.
21. http://genome.ucsc.edu. 2006.
22. Gardiner-Garden M, Frommer M: CpG islands in vertebrate genomes. J Mol Biol 1987, 196:261-282.
23. http://ftp.genome.washington.edu/RM/RepeatMasker.html. 2006.
24. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965, 64:31-49.
25. Chiaravalli AM, Cornaggia M, Furlan D, Capella C, Fiocca R, Tagliabue G, Klersy C, Solcia E: The role of histological investigation in prognostic evaluation of advanced gastric cancer. Analysis of histological structure and molecular changes compared with invasive pattern and stage. Virchows Arch 2001, 439:158-169.
26. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M: AJCC cancer staging maunal 6th edition. Berlin Heidelberg New York, Springer Verlag; 2002.
27. Kim KM, Kwon MS, Hong SJ, Min KO, Seo EJ, Lee KY, Choi SW, Rhyu MG: Genetic classification of intestinal-type and diffuse-type gastric cancers based on chromosomal loss and microsatellite instability. Virchows Arch 2003, 443:491-500.
28. http://www.urogene.org/methprimer. 2006.
29. Sato N, Maitra A, Fukushima N, van Heek NT, Matsubayashi H, Iacobuzio-Donahue CA, Rosty C, Goggins M: Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Cancer Res 2003, 63:4158-4166.
30. Darwanto A, Kitazawa R, Maeda S, Kitazawa S: MeCP2 and promoter methylation cooperatively regulate E-cadherin gene expression in colorectal carcinoma. Cancer Sci 2003, 94:442-447.
31. Oh H, Park Y, Kuroda MI: Local spreading of MSL complexes from roX genes on the Drosophila X chromosome. Genes Dev 2003, 17:1334-1339.
32. Wu MS, Wang HP, Lin CC, Sheu JC, Shun CT, Lee WJ, Lin JT: Loss of imprinting and overexpression of IGF2 gene in gastric adenocarcinoma. Cancer Lett 1997, 120:9-14.
33. Kang MJ, Park BJ, Byun DS, Park JI, Kim HJ, Park JH, Chi SG: Loss of imprinting and elevated expression of wild-type p73 in human gastric adenocarcinoma. Clin Cancer Res 2000, 6:1767-1771.
34. Kim KM, Kim MJ, Cho BK, Choi SW, Rhyu MG: Genetic evidence for the multi-step progression of mixed glandular-neuroendocrine gastric carcinomas. Virchows Arch 2002, 440:85-93.
35. Kwon MS, Hong SJ, Cho HA, Ahn GH, Lee SS, Lee KY, Rhyu MG: Extensive and divergent chromosomal losses in squamous and spindle-cell components of esophageal sarcomatoid carcinoma. Virchows Arch 2003, 443:635-642.
36. Waki T, Tamura G, Tsuchiya T, Sato K, Nishizuka S, Motoyama T: Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia. Am J Pathol 2002, 161:399-403.
37. Akiyama Y, Maesawa C, Ogasawara S, Terashima M, Masuda T: Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells. Am J Pathol 2003, 163:1911-1919.
38. Oue N, Oshimo Y, Nakayama H, Ito R, Yoshida K, Matsusaki K, Yasui W: DNA methylation of multiple genes in gastric carcinoma: association with histological type and CpG island methylator phenotype. Cancer Sci 2003, 94:901-905.
39. Lee JH, Park SJ, Abraham SC, Seo JS, Nam JH, Choi C, Juhng SW, Rashid A, Hamilton SR, Wu TT: Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas. Oncogene 2004, 23:4646-4654.
40. Soundararajan R, Rao AJ: Trophoblast' pseudo-tumorigenesis': significance and contributory factors. Reprod Biol Endocrinol 2004, 2:15.
41. Kim TY, Lee HJ, Hwang KS, Lee M, Kim JW, Bang YJ, Kang GH: Methylation of RUNX3 in various types of human cancers and pre-malignant stages of gastric carcinoma. Lab Invest 2004, 84:479-484.
42. Lund AH, van Lohuizen M: RUNX: a trilogy of cancer genes. Cancer Cell 2002, 1:213-215.
43. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, Markowitz S, Willson JK, Hamilton SR, Kinzler KW, Kane MF, Kolodner RD, Vogelstein B, Kunkel TA, Baylin SB: Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A 1998, 95:6870-6875.
44. Nakagawa H, Nuovo GJ, Zervos EE, Martin EWJ, Salovaara R, Aaltonen LA, de la CA: Age-related hypermethylation of the 5′ region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development. Cancer Res 2001, 61:6991-6995.